6030nok
-1,1 %
Date:2025-05-15Time:14:24:31Latest report:Q1-2025List:Oslo BorsTicker:AKBM
Market Cap:5 288 mnokEnterprise Value:6 937 mnokNet Sales:201,2 musdEarnings:-9,80 musdEmployees:0ISIN:NO0010886625

Ratios

10-year key figure history for Aker BioMarine turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Aker BioMarine with index and moving average MA50 and MA200.

Stockprice:60,30
MA50:56,20
MA200:63,70
Price/MA200:-5,3 %
RSI (14):63,3
Price/MA50:7,3 %

Description

Aker BioMarine is a biotechnology company. The company specializes in the development of dietary supplements. The product portfolio is broad and includes, for example, omega-3 oil, nutritional supplements for animals, and protein supplements for fish farming. The business is run worldwide with the largest presence in the Nordic market. The customers consist of both private actors and wholesalers. Aker BioMarine was founded in 2006 and is headquartered in Oslo.